Pihlajalinna Oyj

Equities

PIHLIS

FI4000092556

Healthcare Facilities & Services

Market Closed - Nasdaq Helsinki Other stock markets 08:59:32 15/05/2024 pm IST			5-day change	1st Jan Change
9.02 ^EUR	-1.74%		+0.45%	+27.76%

03/05	Pihlajalinna Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
30/04	Pihlajalinna Oyj Revises Earnings Guidance for the Year 2024	CI

Pihlajalinna Oyj Provides Consolidated Revenue Guidance for the Year 2023

August 11, 2023 at 10:30 am IST

Pihlajalinna Oyj provided consolidated revenue guidance for the year 2023. For the year, the company expects consolidated revenue to increase from the previous year's level (EUR 690.5 million in 2022).

Latest news about Pihlajalinna Oyj

Pihlajalinna Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05	CI
Pihlajalinna Oyj Revises Earnings Guidance for the Year 2024	30/04	CI
Pihlajalinna plc announces Changes in Management Team	16/04	CI
Pihlajalinna plc Approves Dividend for the Year 2023, Payable on April 19, 2024	10/04	CI
Pihlajalinna plc Announces Board Committee Appointments	10/04	CI
Pihlajalinna Oyj announces an Equity Buyback for 150,000 shares, representing 0.66% for ?1.3 million.	26/03	CI
Pihlajalinna Oyj authorizes a Buyback Plan.	26/03	CI
Pihlajalinna Oyj Proposes Dividend for Financial Year That Ended on 31 December 2023, Payable on 19 April 2024	14/03	CI
Antti-Jussi Aro Decides to Leave Pihlajalinna plc as Chief Information Officer, Effective 10 May 2024	05/03	CI
Finland's Pihlajalinna COO Plans February-end Exit	14/02	MT
Pihlajalinna plc Announces Resignation of Timo Harju as Chief Operating Officer, Private Health Services, Effective 29 February 2024	14/02	CI
Pihlajalinna Oyj Proposes Dividend for the Financial Year Ended on 31 December 2023, Payable on April 19, 2024	14/02	CI
Pihlajalinna Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02	CI
Pihlajalinna Plc Provides Earnings Guidance for the Year 2023	24/01	CI
Pihlajalinna Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11	CI
Pihlajalinna Oyj Reaffirms Revenue Guidance for 2023	03/11	CI
Pihlajalinna's Complete Outsourcing Agreement in the Wellness Services County of South Ostrobothnia Will End in 2025	30/23/30	CI
Pihlajalinna plc and Fennia Deepen the Partnership and Sign a New Co-Operation Agreement	18/23/18	CI
Pihlajalinna Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Pihlajalinna Oyj Provides Consolidated Revenue Guidance for the Year 2023	11/23/11	CI
Pihlajalinna Announces Appointment of Tuomas Hyyryläinen as the CEO, Effective 1 September 2023	06/23/06	CI
Finland's Pihlajalinna Names Fiskars Executive as CEO	28/23/28	MT
Pihlajalinna Oyj Appoints Tuomas Hyyryläinen as CEO	28/23/28	CI
Pihlajalinna Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
Pihlajalinna Oyj Provides Consolidated Revenue Guidance for 2023	28/23/28	CI

Chart Pihlajalinna Oyj

Duration

Period

More charts

Company Profile

Pihlajalinna Oyj is a Finland-based company providing social and healthcare services. It dedicates its offer to individuals, businesses and public institutions. It operates medical and health centers, dental clinics and hospitals around Finland. The Company operates in two segments: Private Clinics and Specialized Care (L&E), which includes medical centers, surgical operations, public specialized care, dental healthcare and occupational health services; and Primary and Social Care (P&S), which comprises social care, outsourcing of healthcare, health packages, and employment services. The Company's activities are conducted under two brands, namely Pihlajalinna and Dextra. Also, it offers wellbeing services through the Forever fitness centre chain.

Sector

Healthcare Facilities & Services

Calendar

09/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Pihlajalinna Oyj

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.02 EUR

Average target price

9.225 EUR

Spread / Average Target

+2.27%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
PIHLAJALINNA OYJ	+27.76%	22Cr
CVS HEALTH CORPORATION	-28.75%	7.03TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.04%	2.75TCr
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.19%	1.78TCr
FRESENIUS SE & CO. KGAA	+2.32%	1.75TCr
QUEST DIAGNOSTICS INCORPORATED	+2.10%	1.55TCr
REDE D'OR SÃO LUIZ S.A.	+7.06%	1.35TCr
FRESENIUS MEDICAL CARE AG	+10.80%	1.31TCr
NATERA, INC.	+71.31%	1.3TCr
TENET HEALTHCARE CORPORATION	+75.96%	1.26TCr

Other Healthcare Facilities & Services